Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients
We evaluated the age-specific mortality of unselected adult outpatients infected with SARS-CoV-2 treated early in a dedicated COVID-19 day hospital and we assessed whether the use of hydroxychloroquine (HCQ) + azithromycin (AZ) was associated with improved survival in this cohort. A retrospective...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
IMR (Innovative Medical Research) Press Limited
2021-09-01
|
Series: | Reviews in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://rcm.imrpress.com/fileup/2153-8174/PDF/1632453113256-204528530.pdf |